This comprehensive overview of the roles of structural, functional, and diffusion MRI, PET, MRS, and MEG serves as a resource for effectively integrating neuroimaging methodologies into the design and execution of Huntington's disease clinical trials. The paper discusses their applications in patient selection, safety monitoring, and demonstrating efficacy.